Jean(Abou Yared)YaredMD

Hematology • Baltimore, MD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Associate Professor of Medicine, Blood and Marrow Transplantation Program, University of Maryland School of Medicine

Join to view full profile

Dr. Yared is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yared's full profile

Already have an account?

Office
22 S Greene St, Room N9E12
Univ. Of Md, Marlene & Stewart Greenebaum Cancer Center
Baltimore, MD 21201
Phone+1 410-328-1230

Fax+1 410-328-1975

Education & Training

University of MarylandFellowship, Hematology and Medical Oncology, 2010 - 2013
Greater Baltimore Medical CenterResidency, Internal Medicine, 2007 - 2010
St Joseph's University Medical SchoolClass of 2002

Certifications & Licensure

NH State Medical License 2013 - Present
MD State Medical License 2013 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Clinical Trials

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation Start of enrollment: 2017 Oct 23
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.
Mehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, John Baddley, Destiny Omili
Blood Advances. 2024-11-26
2 citations
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.
Sanjeet S Dadwal, Rajat Bansal, Michael W Schuster, Jean A Yared, Gary Douglas Myers
Blood Advances. 2024-09-10
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation.
Gabriela Sanchez-Petitto, Olga Goloubeva, James Childress, Tahreem Iqbal, Jack Masur
Acta Haematologica. 2024-08-27

Abstracts/Posters

Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
Jean A. Yared, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
Jean A. Yared, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Other Languages

French, Arabic